Podcast Summary: "Stem Cells & Peptides: The Secret to Reversing Chronic Pain and Aging" featuring Dr. Adil Khan

Episode Details:

• Podcast: The Doctor's Farmacy with Mark Hyman, M.D.
• Host: Dr. Mark Hyman
• Guest: Dr. Adil Khan
• Release Date: November 20, 2024
• Platform: Megaphone

1. Introduction to Regenerative Medicine

Dr. Mark Hyman welcomes Dr. Adil Khan to discuss the burgeoning field of regenerative medicine, emphasizing its potential to revolutionize the treatment of chronic pain and the aging process. Dr. Khan shares his inspiration and journey into regenerative medicine, highlighting the limitations of traditional allopathic medicine and the promise of functional and regenerative approaches.

Notable Quote:

Dr. Adil Khan [05:57]: "Regenerative medicine is a playoff of functional medicine, which is you're trying to restore tissue or restore dysfunction of the cell back to normal."

2. Understanding Stem Cells in Regenerative Medicine

Dr. Khan delves into the complexities of stem cells, clarifying common misconceptions. He distinguishes between true stem cells capable of regenerating tissue and "committed progenitor cells," which primarily reduce inflammation without generating new tissue.

Notable Quote:

Dr. Adil Khan [00:02]: "These things should be called committed progenitor cells... it's just misleading because a lot of patients are like, oh yeah, I got stem cell injections. It wasn't really a stem cell per se. It was more just something to reduce inflammation."

3. Advancements in Stem Cell Technology

The conversation progresses to recent advancements, particularly the development of MU cells (multilineage differentiating stress enduring cells) by Professor Mary Dazawa. These cells are pluripotent, allowing differentiation into over 200 cell types, and are resilient enough to survive harsh environments, enhancing their therapeutic efficacy.

Notable Quote:

Dr. Adil Khan [14:47]: "MU cells are pluripotent and stress enduring, meaning they can survive harsh environments. This ensures they effectively reduce inflammation and repair cellular function."

4. Exosomes: The Power of Cellular Communication

Dr. Khan introduces exosomes, the smallest type of extracellular vesicles, highlighting their role in cell-to-cell communication. Exosomes carry signaling molecules like microRNAs and cytokines, which can modulate the immune system and promote healing. He explains how isolating and concentrating exosomes can enhance their therapeutic potential without the complexities of using whole stem cells.

Notable Quote:

Dr. Adil Khan [35:46]: "Exosomes are packages by which your cell communicates with other cells, helping facilitate cell-to-cell communication and altering the microenvironment favorably."

5. Clinical Applications and Real-World Impact

Dr. Khan shares compelling clinical anecdotes, including successful treatments of ALS patients and stroke survivors using MU cells. He emphasizes the significant improvements in patients' quality of life, such as regained swallowing abilities and return to full-time work, showcasing the tangible benefits of regenerative therapies.

Notable Quote:

Dr. Adil Khan [27:21]: "I just had an ALS patient I treated a couple weeks ago, and she couldn't swallow because of the bulbar symptoms... now she can swallow, she can speak clearly. It was incredible."

6. Peptides and Gene Therapy in Longevity

The discussion shifts to peptides like follistatin and emerging gene therapies such as Clotho gene therapy. Dr. Khan explains how follistatin inhibits myostatin, promoting muscle growth and combating age-related muscle loss (catabolism). He also covers Clotho's role in activating regenerative pathways and protecting against neuronal death, highlighting its potential in extending lifespan and enhancing cognitive health.

Notable Quotes:

Dr. Adil Khan [53:21]: "Follistatin is a bioidentical peptide hormone that helps the body put on more muscle by inhibiting myostatin."

Dr. Adil Khan [60:56]: "Clotho activates WNT genes, facilitating regeneration and repair, and helps mitigate neuronal death."

7. Challenges and the Future of Regenerative Medicine

Dr. Khan addresses the regulatory and financial hurdles facing regenerative medicine in the U.S., contrasting it with Japan's supportive environment. He discusses the necessity of clinical trials for FDA approval and the potential for cost reductions through technological advancements and economies of scale. Despite current limitations, he remains optimistic about mainstream adoption within the next five years.

Notable Quote:

Dr. Adil Khan [45:06]: "Japan has rigorous standards and insurance covers intra-articular stem cell injections, showing what's possible. In the U.S., politics are a significant barrier."

8. Making Regenerative Therapies Accessible

Highlighting his efforts to make regenerative treatments more accessible, Dr. Khan mentions his clinics in Los Cabos, Mexico, and Europe, as well as partnerships in Tokyo and plans for Abu Dhabi. He underscores the importance of patient-driven demand and early adopters in accelerating the adoption of these therapies.

Notable Quote:

Dr. Adil Khan [73:12]: "Our company is called Eterna... We are investing our profits back into R&D to push this field forward and make it accessible to the average person."

Conclusion

Dr. Mark Hyman and Dr. Adil Khan conclude by reiterating the transformative potential of regenerative medicine. They encourage listeners to explore these options and stay informed about ongoing advancements. Dr. Khan expresses gratitude for the opportunity to discuss these cutting-edge therapies and emphasizes the importance of patient advocacy in driving change within the healthcare system.

Notable Quote:

Dr. Adil Khan [72:01]: "Patients have the right to have all their options explored, especially options that are safe and can be as effective as surgery."

Key Takeaways:

• Regenerative Medicine Overview: An interdisciplinary field aiming to restore function by repairing or replacing damaged cells, tissues, and organs.
• Stem Cells vs. Progenitor Cells: True stem cells can differentiate into various cell types, whereas progenitor cells primarily reduce inflammation.
• Advancements in Stem Cells: MU cells offer enhanced pluripotency and resilience, leading to more consistent therapeutic outcomes.
• Exosomes: Critical for intercellular communication, exosomes can modulate immune responses and promote healing without the need for whole-cell therapies.
• Peptides and Gene Therapy: Innovations like follistatin and Clotho gene therapy hold promise for combating muscle loss, chronic inflammation, and extending lifespan.
• Challenges: Regulatory barriers and high costs in the U.S. hinder mainstream adoption, contrasting with supportive environments like Japan.
• Future Outlook: Ongoing research, technological advancements, and patient advocacy are pivotal for integrating regenerative therapies into standard healthcare practices.

For more information on regenerative medicine and available treatments, visit Eterna Health or follow Dr. Adil Khan on Instagram @dradilkhan.